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Abstract: Previously published data from our group and others demonstrate that human milk
oligosaccharide (HMOs), as well as milk and infant fecal microbial profiles, vary by geography.
However, little is known about the geographical variation of other milk-borne factors, such as lactose
and protein, as well as the associations among these factors and microbial community structures in milk
and infant feces. Here, we characterized and contrasted concentrations of milk-borne lactose, protein,
and HMOs, and examined their associations with milk and infant fecal microbiomes in samples
collected in 11 geographically diverse sites. Although geographical site was strongly associated with
milk and infant fecal microbiomes, both sample types assorted into a smaller number of community
state types based on shared microbial profiles. Similar to HMOs, concentrations of lactose and
protein also varied by geography. Concentrations of HMOs, lactose, and protein were associated
with differences in the microbial community structures of milk and infant feces and in the abundance
of specific taxa. Taken together, these data suggest that the composition of human milk, even
when produced by relatively healthy women, differs based on geographical boundaries and that
concentrations of HMOs, lactose, and protein in milk are related to variation in milk and infant fecal
microbial communities.
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1. Introduction
Human milk is a complex biological fluid that provides all the nutritional require-
ments that support infant growth and development. This is, in part, attributed to the
fact that milk is a rich source of lactose, lipids, human milk oligosaccharides (HMOs),
protein, and numerous other micronutrients [1]. Additionally, both culture-dependent and
culture-independent methods have demonstrated the presence of microbiota in milk [2–6],
with emerging data suggesting that these microbiota may play a role in seeding or supple-
menting the nascent infant gastrointestinal (GI) microbiome [7].
In addition to supporting infant development, milk constituents (including lactose,
protein, and HMOs) both directly and indirectly modulate host-associated microbial com-
munities. As the principal carbohydrate source in milk, lactose is generally digested
in the small intestine via lactase. Undigested lactose that reaches the large intestine is
readily metabolized, and occasionally preferred over glucose, by resident microbes, in-
cluding Lactobacillus and Bifidobacterium, into short-chain fatty acids and other volatile
compounds [8–11]. Similarly, while most proteins are completely digested in the small
intestine [1], partially digested proteins reaching the large intestine may be utilized by
microbes [12]; although this is understudied in infants. In addition, some proteins (e.g.,
lactoferrin and secretory immunoglobulin A) function as host defense agents, modulating
bacterial composition in the infant’s GI tract by repressing growth of pathogens.
In contrast to lactose and protein, HMOs largely pass through the GI tract intact,
as infants lack the enzymes to digest them [13,14]. Upon reaching the large intestine
HMOs function principally as substrates for host-associated microbiota. However, HMOs
not only promote the growth of microbes that are generally considered beneficial (e.g.,
Bifidobacterium [15]), they also function as antimicrobials that protect against pathogens, all
of which contribute to shaping the infant GI microbiome and, in turn, infant health [16–21].
Results from the INSPIRE study (a large geographically and socioculturally diverse
cohort) have previously demonstrated that the profiles of milk-borne immune factors [22],
HMOs [23], and maternal and infant microbiomes [24,25] vary substantially across geo-
graphical/sociocultural boundaries. As HMOs and other components of milk, including
lactose and protein, are able to shape microbial abundance, we hypothesized that variation
in these milk factors could be related to differences in the structure of milk and infant fecal
microbial communities, as well as to the abundance of specific bacterial taxa. To test this
hypothesis, we investigated relationships between and among microbial communities, and
the concentrations of milk lactose, protein, and HMOs in milk and infant fecal samples
collected from maternal–infant dyads in the INSPIRE study.
2. Materials and Methods
2.1. Study Design
The participants in this study were recruited as part of the INSPIRE study, which has
been described in detail [22–25]. All study procedures were approved by the Washington
State University Institutional Review Board (#13264) and at each study location. Sample
collection took place between May 2014 and April 2016 and was carried out as a cross-
sectional, epidemiological, multi-cohort study. Briefly, samples were collected from 11
populations, including two from Ethiopia (rural population, ETR; urban population, ETU);
Kenya (KE), Ghana (GN), two from The Gambia (rural population, GBR; urban population,
GBU), Peru (PE), Spain (SP), Sweden (SW), and two from the United States of America
(California, USC; Washington/Idaho, USW). To be eligible to participate, women had to be
nursing or pumping ≥5 times a day and be ≥18 years of age. Exclusion criteria included:
(1) current indication of a breast infection or breast pain that the woman did not consider
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normal for lactation; (2) illness (i.e., self-reported fever, vomiting, severe cough, or diarrhea)
in the last 7 days; and/or (3) antibiotic use in the previous 30 days. For inclusion, infants
had to be described as healthy by their mothers, have no signs of acute illness (i.e., fever,
vomiting, severe cough, diarrhea, or rapid breathing) in the previous 7 days, and have not
received antibiotics in the previous 30 days.
2.2. Milk and Infant Fecal Sampling
A total of 412 milk and 406 infant fecal samples were collected as part of the INSPIRE
cohort. Descriptions of the sampling protocols for milk and feces have been previously
described [24]. Briefly, milk was collected using gloved hands by participants or research
personnel, after twice cleaning the breast with prepackaged castile soap towelettes (PDI,
Inc, Woodcliff Lake, NJ, USA). Milk samples were collected via electric pump (Symphony,
Medela Inc., Switzerland; PE, SW, USC, USW) or hand expression (ETR, ETU, KE, GN, GBR,
GBU, SP) into sterile containers. Collected milk was immediately frozen (−20 ◦C), except in
ETR where it was preserved in a 1:1 ratio with Milk Preservation Solution (Norgen Biotek,
Ontario, CA) and frozen within 6 days. Approximately 1 g of feces was collected from
diapers (Parent’s Choice; Walmart, Bentonville, AR, USA) or directly from the infant’s skin
using a sterile, single-use scoop (Sarstedt AG & Co., Nümbrecht, Germany). Fecal samples
were then placed into the accompanying sterile polypropylene container and frozen at
−20 ◦C within 30 min of collection. For fecal samples collected in ETR, RNAlater (Ambion,
Austin, TX, USA) was added to each fecal sample in a ∼1:4 ratio (feces:preservative) and
frozen within 6 days. Milk and fecal samples were shipped on dry ice to the University of
Idaho, where they were immediately frozen at −20 ◦C.
2.3. DNA Extraction and 16S rRNA Gene Amplification/Sequencing
DNA was extracted from milk and infant fecal samples as previously described [24].
Extracted DNA from milk and infant fecal samples was subjected to a dual-barcoded,
two-step, 30-cycle polymerase chain reaction (PCR) to amplify the V1-V3 hypervariable
region of the 16S rRNA gene. In the first step, a 7-fold degenerate forward primer tar-
geting nucleotide position 27 [26] and a reverse primer targeting nucleotide position 534
(positions numbered according to the Escherichia coli 16S rRNA gene) were used as de-
scribed previously [27]. Amplicons were pooled to contain 50 ng of DNA from each
sample. Size selection of amplicon pools were performed using AMPure beads (Beckman
Coulter, Indianapolis, IN, USA), quality checked on a Fragment Analyzer (Advanced Ana-
lytical Technologies, Inc., Ankeny, IA, USA), and quantified using the KAPA Biosciences
Illumina library quantification kit and Applied Biosystems StepOne Plus real-time PCR
system. Amplicons passing quality control for milk and feces were sequenced by sample
type on separate MiSeq (Illumina, San Diego, CA, USA) sequencing runs (v3 paired-end,
300-bp protocol for 600 cycles at the University of Idaho Institute for Bioinformatics and
Evolutionary Studies Genomics Core).
2.4. 16S rRNA Gene Amplicon Data Processing
Samples were processed as previously described [24], with the following modifications.
The DADA2-silva-derived taxonomy was edited to replace “NA” classifications with the
next highest classification (e.g., if an amplicon sequence variant, ASV, was unclassified at
the genus level but was classified at the family level as “Prevotellaceae”, it was given a
genus-level classification of “Family_Prevotellaceae”). The ASV table was then filtered to
remove ASVs assigned to mitochondria and chloroplasts. Furthermore, prevalence-based
filtering to identify and remove potentially confounding sequences from milk samples
that may have inadvertently arisen through sample collection, preparation, and reagent
contamination [28,29], despite exercising aseptic technique [24], was performed using the
R package decontam (v. 0.99.1) [30]. DNA extraction blanks (n = 23), generated and treated
in parallel with milk samples, were used as negative controls in the filtering. As ETR milk
samples were collected and stored using a preservative, these samples (n = 40) and their
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respective negative controls (n = 5) were processed through decontam separately from
the remaining cohort samples (n = 390) and their respective negative controls (n = 18).
ASV tables were used as the input for the isNotContaminant function using the default
parameters (method = “prevalence”, threshold = 0.5). After removing negative controls
and ASVs lacking statistical support, ASV tables were merged in phyloseq and samples
with less than 1000 reads (and their respective paired milk or infant fecal sample) were
removed. An overview of the relative abundances of the most abundant genera before and
after decontam filtering is presented in Figure S1 and a R markdown file containing code
for decontam is included as a supplemental file.
2.5. Microbial Community State Type Analysis
The R package DirichletMultinomial (v. 1.20.0) [31] was used to describe variability
in microbiome data and cluster samples into community state types (i.e., “microbial lacto-
types” for milk samples and “enterotypes” for infant fecal samples) based on the genus
level abundance tables (filtered to remove genera present across all samples with a relative
abundance of less than 0.01%). Model fit was determined based on the minimum Laplace
goodness of fit.
2.6. Microbial Alpha and Beta Diversity
For alpha and beta diversity analyses, samples were rarefied to 95% of the minimum
sample read count. The rarefied data were used to generate the Bray–Curtis dissimilarity
distance matrix, or converted to binary counts to generate the binary Jaccard distance
matrix, and used for multidimensional scaling (MDS) and non-metric multidimensional
scaling (NMDS). For MDS, the vegan adonis function was used to perform permutational
multivariate analysis of variance (PERMANOVA) with 999 permutations to test for differ-
ences between groups. The vegan envfit function was used to fit and determine goodness
of fit and p-values for selected maternal and environmental factors (e.g., maternal body
mass index (BMI), mode of delivery, and HMOs concentration) onto the Bray–Curtis NMDS
ordination data using 9999 permutations.
2.7. Milk Composition Analysis
Descriptions of the processing and analysis protocols for milk composition, includ-
ing HMOs, have been previously described in detail [23]. HMOs quantified included:
2′-fucosyllactose (2′FL), 3-fucosyllactose (3FL), lacto-N-neotetraose (LNnT), 3′-sialyllactose
(3′SL), difucosyllactose (DFlac), 6′-sialyllactose (6′SL), lacto-N-tetraose (LNT), lacto-N-
fucopentaose (LNFP) I, LNFP II, LNFP III, sialyl-LNT (LST) b, LSTc, difucosyllacto-
LNT (DFLNT), lacto-N-hexaose (LNH), disialyllacto-N-tetraose (DSLNT), fucosyllacto-N-
hexaose (FLNH), difucosyllacto-N-hexaose (DFLNH), fucodisialyllacto-lacto-N-hexaose
(FDSLNH) and disialyllacto-N-hexaose (DSLNH). HMOs were also grouped for analyses
based on structural features and ratios: small HMOs (2′FL, 3FL, 3′SL, 6′SL, and DFLac),
modified lactose (small HMOs and lactose), type 1 HMOs (LNT, LNFP I, LNFP II, LSTb,
and DSLNT), type 2 HMOs (LNnT, LNFP III, and LSTc), α-1-2-fucosylated HMOs (2′FL
and LNFP I), terminal α-2-6-sialylated HMOs (6′SL and LSTc), internal α-2-6-sialylated
HMOs (DSLNT and LSTb), terminal α-2-3-sialylated HMOs (3′SL and DSLNT), ratio of
HMO-bound sialic acid (Sia) to total HMOs (HMO-bound Sia/total HMOs), ratio of HMO-
bound fucose (Fuc) to total HMOs (HMO-bound Fuc/total HMOs), and ratio of the ratio of
HMO-bound Fuc to HMO-bound Sia (HMO-bound Fuc/HMO-bound Sia). Maternal secre-
tor status phenotype was determined based on 2′FL presence or near absence (secretors,
≥200 nmol/mL; non-secretors, <200 nmol/mL) in the milk. Lactose concentrations were
characterized using spectrophotometric assays as described previously [21]. Protein con-
centrations were characterized using the Pierce bicinchoninic acid (BCA) assay (Cat#23225,
Thermo Scientific, Waltham, MA, USA) using whole milk, diluted 1:20 with nanopure
water, following manufacturer recommendations.
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2.8. Statistical Analysis
All statistical analyses were performed using R (v. 3.4.3 or v. 3.6.1). p Values were
calculated using the Kruskal–Wallis test (followed by Dunn’s post hoc test, when applica-
ble), Wilcoxon rank test, and Chi-squared test where appropriate. Infant weight-for-length
z-scores were calculated using the R package zscorer (v. 0.3.1) [32]. The R packages vegan
(v. 2.5-2) [33], phyloseq (v. 1.23.1) [34], ggplot2 (v. 3.0.0) [35], and pheatmap (v. 1.0.8)
were used to perform and/or visualize alpha and beta diversity analyses, ordinations and
cluster analyses. Taxonomic indicator values (IndVal) were calculated using the labdsv
(v. 1.8-0) R package [36]. The R packages Hmisc (v. 4.4.2) [37] and corrplot (v. 0.84) [38]
were used to perform and project Spearman correlations, respectively, among bacterial
genera (relative abundance ≥1% within sample types), lactose, protein, and HMOs. Where
applicable, p values were FDR corrected with the R p.adjust function. Values are given as
mean ± standard deviation (SD), unless otherwise indicated. Statistical significance was
declared at p < 0.05 and/or FDR p ≤ 0.1.
3. Results
3.1. Cohort Demographics
Data for 357 maternal–infant dyads were available for analyses after microbiome
sequence processing and quality control. On average, maternal age was 27.4 ± 6.1 years,
with milk and infant fecal samples collected an average of 64.6 ± 21.9 days postpartum.
Overall, the majority (86%) of births were via vaginal delivery, and the frequency of
exclusive breastfeeding at the time of sample collection was 60%. Consistent with prior
reports of the INSPIRE cohort [22–25], there were myriad differences in demographics
across populations. Additional selected demographics for these dyads are detailed in
Table S1.
3.2. Milk and Infant Fecal Microbiomes
We observed a total of 5303 ASVs, of which 2085 were observed in milk (14,525 ±
15,479 average reads) and 3935 were observed in infant fecal samples (11,544 ± 6029 av-
erage reads), respectively. These ASVs corresponded to 22 phyla and 486 genera, with
milk containing 21 phyla and 363 genera and infant feces containing 12 phyla and 272
genera. Principal coordinates analysis confirmed that milk and infant fecal microbiomes
differed with respect to community structure and membership (Figure S2). Milk samples
were dominated by Staphylococcus (28%, mean relative abundance) and Streptococcus (26%),
followed by Corynebacterium (6%), Propionibacterium (Cutibacterium; 5%), unclassified Xan-
thomonadaceae (3%), and Lactobacillus (3%) (Figure S2C). Two thirds of the overall relative
abundance of microbiota in infant feces was attributed to five genera: Streptococcus (17%),
Escherichia/Shigella (16%), Bifidobacterium (12%), Veillonella (12%), and Bacteroides (10%)
(Figure S2C).
Community state type (CST, communities of similar microbial composition and abun-
dance) analysis has been used to explore variation of the microbial communities of the
feces (i.e., enterotypes) [39–42], vagina [43], and milk [3]. To identify and examine CSTs,
we applied Dirichlet multinomial mixtures modelling to both milk and infant fecal micro-
biomes. Milk samples formed four clusters or microbial lactotypes (i.e., L1 through L4)
(Figure 1A), whereas infant fecal samples formed two clusters or microbial enterotypes
(i.e., E1 and E2) (Figure 1B). Both microbial lactotypes and enterotypes differed with re-
spect to parity, maternal age, maternal BMI, and exclusive breastfeeding status (Tables S2
and S3). Lactotypes also differed by time postpartum and maternal secretor status. The
distribution of populations within milk and infant fecal CSTs varied. Among lactotypes, L4
was comprised exclusively of rural Ethiopian (ETR) subjects, although not all ETR subjects
belonged to the L4 cluster (Figure 1A). L1 was mainly comprised of individuals from
the Americas and Europe (i.e., PE, SP, SW, USC, and USW), while L2 and L3 were both
largely comprised of individuals from Africa (i.e., L2-ETU, GBR, GBU, and KE; L3-GN),
although L3 contained a marginal proportion of participants from the SP cohort. Similarly,
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infant enterotype membership varied largely by African and non-African populations,
with individuals from the Americas and Europe grouping mainly with E1 (Figure 1B). An
assessment of the relationship between infant fecal enterotypes and the lactotypes of their
respective mothers revealed mothers with milk that belonged to L1 or L3 had a larger
proportion of infants that belonged to E1 (67% and 63%, respectively); mothers with milk
that belonged to L2 had a larger proportion of infants that belonged to E2 (60%). However,
infants of mothers with milk that belonged to L4 were split between E1 (49%) and E2 (51%).
The abundance and prevalence of several genera were associated with individual milk
and infant fecal CSTs based on indicator species analysis (Figure 1; FDR p < 0.1) (Tables S4
and S5). Among the most abundant genera within milk, Streptococcus, Propionibacterium,
Lactobacillus, and Corynebacterium were identified as indicator taxa for L1, L2, L3, and L4,
respectively. Bifidobacterium was also identified as an indicator taxon of L4. Among the
most abundant genera within infant feces, Bacteroides, Escherichia/Shigella, and Clostridium
sensu strictu were identified as indicator taxa of E1, whereas Streptococcus, Bifidobacterium,
Lactobacillus, and Staphylococcus were identified as indicator taxa of E2.
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for the full list of indicator taxa of individual CSTs.
CSTs also differed from one another across multiple alpha (i.e., Shannon diversity,
observed ASVs, and Pielou’s evenness) and beta (i.e., Bray–Curtis and binary Jaccard)
diversity metrics (Figure S3). In general, both Shannon and observed ASV metrics were
highest in L4 and lowest in L3, with similar differences with respect to Pielou’s evenness
(Figure S3A). In contrast, there were no difference in alpha diversity metrics between
infant fecal enterotypes (Figure S3B). Examination of the beta diversity of milk microbial
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lactotypes and infant fecal enterotypes confirmed that CSTs differed in community structure
and membership (PERMANOVA, p < 0.001; Figure S3C,D).
In summary, although milk and infant fecal microbiomes share numerous taxa, the
microbial communities of these sample types differ. Additionally, despite the gradients
of taxa abundances within these microbial communities, the microbiomes of milk and
infant feces can be classified into multiple CSTs that are related to both maternal and infant
factors, as well as to the presence and abundance of indicator genera.
3.3. Milk Lactose and Protein Concentrations
In milk, and similar to prior reports [1,44], average concentrations of lactose and
protein were 79.2 ± 11.0 g/L and 15.0 ± 2.8 g/L, respectively. There was substantial
variation in the range of concentrations for both of these milk constituents, with lactose
ranging from 26.7 to 118.3 g/L (interquartile range [IQR], 72.7 to 84.3 g/L) and protein from
9.4 to 32.6 g/L (IQR, 13.2 to 16.6 g/L; Figure 2). The average concentrations of both lactose
and protein differed by population (p < 0.001, both; Figure 2A). While lactose concentration
differed among lactotypes (p = 0.008), protein concentration did not (p = 0.348; Figure 2B).
Although the concentration of lactose did not differ between enterotypes (p = 0.553), a
trend was observed for protein concentration (p = 0.051; Figure 2C).
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terotypes. p Values were calculated from Kruskal–Wallis test (followed by Dunn’s post hoc test;
letters above the group names along the x-axes denote significance groups, p < 0.05).
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3.4. Concentration and Composition of HMOs
Average concentration of total HMOs in milk was 12,913 ± 4039 nmol/mL (range,
4053–22,884 nmol/mL; IQR, 9735–15,847 nmol/mL). As expected and previously shown [23],
concentration of 2′FL was most associated with HMO composition profiles (Figure S4).
Although multiple differences in HMO concentrations were observed among microbial
lactotypes, fewer differences were observed between enterotypes (Tables S6 and S7). When
microbial lactotypes and enterotypes were considered, concentrations of four HMOs dif-
fered in both (DSLNT, LSTc, LNnT, and 3′SL; FDR p < 0.1). An additional 12 HMOs differed
in concentration among microbial lactotypes, and 3FL differed in concentration between
enterotypes. Examination of the concentrations of HMOs grouped by shared features (e.g.,
HMO-bound fucose) or fucose/sialic-acid-bound HMOs within CSTs revealed that almost
all groups differed among microbial lactotypes, except for type 1 and type 2 HMOs. In
contrast, fewer HMO groupings differed between enterotypes, although differences were
observed in the concentrations of type 2 HMOs and HMOs with internal α-2-6-sialyated
linkages. Significant differences in the ratios of HMO-bound fucose to HMO-bound sialic
acid as well as to total HMOs were also observed among lactotypes but not between
enterotypes.
3.5. Association between Milk Composition and Milk and Infant Fecal Bacterial Beta Diversity
As microbial communities are comprised of taxa present in gradients of abundance,
we examined the association of maternal/infant characteristics and the concentrations
of milk-borne lactose, protein, and HMOs to the overall microbial community structure
of milk and infant fecal samples using envfit. Not surprisingly, for both milk and infant
fecal microbiomes, population cohort and respective CSTs were significantly associated
with microbial composition (20 to 37% of the explained variance in milk and infant fecal
microbiomes; Figure 3). Microbial lactotype was significantly associated with infant fecal
microbiota community structure (~8%), but not the inverse. Maternal age, parity, and
exclusive breastfeeding were also associated with the composition of both milk and infant
fecal microbiomes, whereas time postpartum, maternal BMI, and mode of delivery were
only associated with the infant fecal microbiome.
Numerous associations were also identified between the concentrations of milk-borne
factors and microbial community structure (Figure 3). For instance, variation in lactose
concentration was associated with the microbial community structure of milk (~4% ex-
plained variance) but not infant feces. In contrast, variation in protein concentration was
associated with the structure of the infant fecal (~3%) microbiome, but not that of milk.
Individually, 3FL, DSLNT, and 2′FL explained the most variance within both microbiomes
(>4%, each), with an additional seven and eight HMOs also associated with milk and
infant fecal microbiomes, respectively. Examination of HMOs by shared characteristics
revealed that the concentration of HMO-bound fucose explained the most variance within
the milk microbiome (~7%), and the ratio of HMO-bound fucose to HMO-bound sialic acid
explained the most variance within the infant fecal microbiome (~12%). Thus, variation
in milk and infant fecal microbiomes were related to differences in maternal and infant
characteristics, as well as the concentrations of milk-borne factors.
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2′-fucosyllactose (2′FL), 3-fucosyllactose (3FL), lacto-N-neotetraose (LNnT), 3′-sialyllactose (3′SL), difucosyllactose (DFlac),
6′-sialyllactose (6′SL), lacto-N-tetraose (LNT), lacto-N-fucopentaose (LNFP) I, LNFP II, LNFP III, sialyl-LNT (LST) b, LSTc,
difucosyllacto-LNT (DFLNT), lacto-N-hexaose (LNH), disialyllacto-N-tetraose (DSLNT), fucosyllacto-N-hexaose (FLNH),
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α-2-6-sialylated HMOs (6′SL and LSTc), internal α-2-6-sialyl ted HMOs (DSLNT and LSTb), terminal α-2-3-si lylated
HMOs (3′SL and DSLNT), ratio of HMO-bound sialic acid (Sia) to total HMOs (HMO-bound sialic acid/total HMOs), ratio
of HMO-bound fucose (Fuc) to total HMOs (HMO-bound fucose/total HMOs), and ratio of the ratio of HMO-bound Fuc to
HMO-bound Sia (HMO-bound fucose/HMO-bound sialic acid).
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3.6. Correlation of Milk Factors with Bacterial Taxa Abundance
A correlation analysis was performed to identify associations between and among
concentrations of milk lactose, protein, HMOs, and the relative abundances of specific bac-
terial genera in milk and infant feces. Similar to prior observations of the milk microbiome
and HMOs [19], stronger correlations were observed within a class of constituents (e.g.,
HMO-to-HMO and bacterium-to-bacterium) than between milk macronutrients/HMO and
bacterial taxa (Figure 4). This was mainly attributed to the grouping of HMOs with shared
features such as α-1-2-fucosylated HMO (e.g., 2′FL and LNFP I, $ = 0.74) or sialylated
HMOs (e.g., 6′SL and LSTc, $ = 0.65). Significant bacterium-to-bacterium correlations were
also observed within and among milk and infant fecal samples. With respect to bacteria,
the strongest inverse associations were observed between Bacteroides and Streptococcus in
infant feces ($ = −0.40), Dyella and Rhizobium in milk ($ = −0.38), and Gemella in milk and
Lactobacillus in infant feces ($ = −0.29). The strongest positive associations were observed
between Dyella and unclassified Xanthomonadaceae in milk ($ = 0.68), Corynebacterium 1
and Kocuria in milk ($ = 0.43), Bacteroides and Parabacteroides in infant feces ($ = 0.42), and
Bifidobacterium and Kocuria in milk ($ = 0.41). Interestingly, while the relative abundances of
Lactobacillus were positively correlated between infant fecal and milk samples ($ = 0.36), the
relative abundances of Bifidobacteria in feces and milk were inversely correlated ($ = −0.18).
Associations were also observed between milk constituents and both milk and infant
fecal microbiota (Figure 4). For example, the relative abundances of milk and infant
fecal Lactobacillus were inversely related to concentrations of fucosylated HMOs, whereas
relative abundances of milk and infant fecal Veillonella were inversely correlated with
concentrations of sialylated HMOs. Given the specific adaptations for HMO utilization of
specific Bifidobacteria species, it is noteworthy that the abundance of infant fecal Bifidobacteria
was only significantly associated with the concentration of fucosylated HMOs, except for
an inverse correlation with DFLNH; however, the relative abundance of milk Bifidobacteria
was inversely related to the concentration of several fucosylated HMO, including 2′FL.
Positive correlations were observed between milk and infant fecal Bifidobacteria with DSLNT,
DSLNH, and other sialylated HMOs. In contrast, Streptococcus in milk (but not infant feces)
was positively associated with fucosylated HMOs. Correlations between the relative
abundance of bacteria in milk and infant feces and the concentrations of protein and lactose
were few and weak; although, in general, correlations between bacteria and lactose tended
to be stronger than those between bacteria and protein. Taken together, although within
class associations of milk-borne factors were stronger, numerous associations between
these same factors and specific milk and infant fecal microbiota were identified.
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4. Discussion
Human milk contains a diversity of nutrients and bioactive factors known or postu-
lated to influence maternal and infant health. Here we tested the hypothesis that variation
in the concentrations of milk lactose, protein, and HMOs would be associated with dif-
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ferences in the community structure and abundance of milk and infant fecal microbiota.
Although milk and infant fecal microbiota are known to vary by geographical location, we
found milk and infant fecal microbiota grouped into four microbial lactotypes and two
enterotypes, respectively, based on similarities in community composition. Interestingly,
while the CSTs within milk and infant feces contained representative genera (e.g., Lacto-
bacillus in L3 and Bacteroides in E1), several genera were shared among all samples; for
example, Staphylococcus and Veillonella were core genera in milk and infant fecal samples,
respectively.
Interestingly, despite Staphylococcus spp. (e.g., Staphylococcus aureus) being commonly
implicated as a common etiological agent of mastitis [45,46], mastitis was not reported by
any of the women in the current study. Indeed, Staphylococcus spp. are common constituents
of milk microbial communities [3,47,48]. While differences in traits and virulence factors
among strains of staphylococci [49] may help to partially explain why not all carriers
of Staphylococcus spp. go on to develop mastitis, it also indicates that the presence of
Staphylococcus spp. in milk alone is not sufficient to treat with antibiotics, and that more
research related to the microbial etiology of mastitis is needed.
Similar to HMOs, concentrations of lactose and protein displayed a substantial amount
of interindividual variation that differed among population cohorts and CSTs. Concentra-
tions of HMOs are largely determined by genetic factors [50]. For example, individuals
with a functioning FUT2-encoded fucosyltransferase (i.e., secretors) are able to synthe-
size α-1-2-fucosylated HMOs such as 2′-fucosyllactose (2′-FL) and lacto-N-fucopentaose
I (LNFP I), whereas individuals lacking a functional FUT2 allele (i.e., non-secretors) are
unable to synthesize these glycans [51]. Less is known about the underlying genetics
that contribute to the concentrations of milk lactose and protein. There are some data
that suggest host genetics may play a role in milk lactose concentrations; e.g., lactose
concentrations differ among ABH and Lewis secretor types [52], and differences in lactose
concentrations have been observed in milk produced by women living in five different
countries using metabolomics [53]. In contrast, while single nucleotide polymorphisms
impacting bioactivity of some milk proteins have been identified [54], none have been
strongly related to differences in milk protein concentration [55]. Regional differences in
maternal nutrition may explain some of the variation in concentrations that we observed,
although this is unlikely to be a significant contributor as both milk lactose and protein
levels are relatively unaltered by diet [56,57]. The full extent of the impact of host genetics
on lactose and total protein concentrations remains to be determined.
The variation in protein and lactose concentrations among population cohorts may
also have implications for current recommendations for dietary consumption of these
nutrients. Adequate intake (AI) levels of nutrients for infants from 0 to 6 months are
estimated based on an exclusive human milk diet (average concentration of the nutrients
in milk coupled with milk intake volume of 0.78 L/d) by healthy, full-term infants born to
healthy, well-nourished mothers [58]. For example, the AIs for carbohydrates (in human
milk being almost exclusively lactose) and protein are 74 g/L and 11.7 g/L, respectively [58].
In the present study, 70 percent of overall participants produced milk that met or exceeded
the value used to establish the AI for carbohydrates/lactose. However, this varied by
cohort, ranging from 47 percent of USW women to 100 percent of USC women. Similarly,
whereas 92 percent of overall participants produced milk with protein concentrations that
met or exceeded the value used to establish the AI for protein, this ranged from 66 percent
of USW women to 100 percent of GBR and PE women. Although in the current study
we did not assess milk intake volume of the infants, the differences in concentrations of
lactose and protein across cohorts suggest that average consumption of these important
macronutrients may differ by population.
The complex microbial communities present in milk and infant feces were associ-
ated with numerous maternal/infant factors as well as milk HMO, lactose, and protein
concentrations. Not surprisingly, based on prior data [24], population cohort explained
the most variance within both microbiomes; however, maternal age, parity, and exclusive
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breastfeeding were also significantly associated with variation. Interestingly, microbial lac-
totype was significantly associated with variation in the infant fecal microbiome, in support
of the hypothesis that milk microbiota contribute to and influence infant GI microbiome
composition [4,7,59].
While the proportion of secretors differed among microbial lactotypes, maternal
secretor status per se was not associated with the microbial community structure of milk
or infant fecal microbiota, consistent with findings from the CHILD and TwinsUK study
cohorts [19,60]. Instead, microbial community structures of milk and infant fecal samples
were associated with concentrations of α-1-2-fucosylated HMOs and HMO-bound fucose.
This is likely related to underlying host genetics that results in a large degree of variation
in the concentrations of α-1-2-fucosylated HMOs in the milk produced by secretors [23].
Although we did not analyze dietary patterns in this study, maternal diet may play a role
in altered patterns of α-1-2-fucosylated HMO composition [61].
Several other HMOs (e.g., 3FL, LNFP III, LSTb, and DSLNT) were also found to
be related to the microbial community structures of milk and infant feces. Interestingly,
DSLNT, hypothesized to protect against necrotizing enterocolitis [62–64], was among the
top three HMOs that explained the most variance in the structure of both milk and infant
fecal microbiomes. In a correlation analysis, DSLNT was also positively associated with
the abundance of Bifidobacterium in both milk and infant feces; Bifidobacterium is considered
to be health-promoting during infancy [65] and has been found to positively correlate with
DSLNT concentrations in milk [64]. It is notable that all the infants in this study were
reported as born at term and currently healthy.
While concentrations of lactose were associated with the microbial community struc-
ture of milk, concentrations of protein were not. Conversely, while concentrations of protein
were associated with the microbial community structure of infant feces, concentrations of
lactose were not. These differences are likely reflective of host factors and in the microenvi-
ronment of the mammary gland and the GI tract. For example, lactose plays a major role in
controlling milk volume via maintenance of the osmolarity of milk in the mammary gland
and is mostly metabolized prior to reaching the lower GI tract. Lactose concentrations
were positively correlated with the abundance of Streptococcus in milk, a genus known to
be capable of fermenting lactose. However, given the abundance of lactose in milk, it is
unlikely to be a rate-limiting substrate for bacterial growth. Instead, lactose may function
to modulate bacterial abundance by inducing metabolization of other milk-borne factors,
similar to HMO-induced amino acid utilization [66]; however, this remains to be examined.
Several limitations to the current study should be noted. As we only examined total
protein, we were unable to examine associations among microbiota and individual proteins
or classes of proteins, such as secretory immunoglobulin A and lactoferrin, both of which
can directly influence microbial ecology [67,68]. Additionally, although we examined
the associations between microbiota and concentration of 19 HMOs that represent the
majority of HMOs present in milk, to date over 200 HMO species (most present in low
abundance) have been identified in human milk [69]. However, the 19 analyzed HMOs
not only represent the majority of all HMOs by mass, they also describe the entire known
chemical space of HMOs, including type 1 and 2 structures, branching, as well as all types
of fucosylation and sialylation. Whether the other more complex (structure redundancy)
and less abundant HMOs have an impact on milk and infant fecal microbiota is unknown
and needs additional research. Finally, HMO concentrations were only measured in milk
and not infant feces; as such we could not examine how HMOs may have been metabolized
as they pass through the infant GI tract and any relationships with resident microbiota.
Additionally, while we attempted to standardize and/or optimize milk and fecal collection,
handling, and analysis protocols, due to practical considerations this was not always
possible. For example, lack of access to reliable refrigeration required us to mix and store
all ETR samples with a preservative, which may have influenced downstream analyses.
However, key strengths of this work are the large and globally diverse cohort of dyads;
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recruitment of relatively healthy participants in each cohort; and inclusion of appropriate
controls and filtering parameters applied prior to analysis.
5. Conclusions
Taken together, our results demonstrate that variation in human milk and infant fecal
microbial communities are associated with differences in the concentrations and profiles of
milk lactose, protein, and HMOs. Future work should focus on understanding how these
associations develop and mature over the course of lactation and infant development.
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